Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© Nicholas Wald and Ian Leck, 2000. All rights reserved. This chapter discusses screening for maternal anaemia and thrombocytopaenia and fetal allo-immune thrombocytopaenia (FAIT) during pregnancy. The use of haemoglobin measurement to detect maternal anaemia is held to be justified, but screening for maternal thrombocytopaenia by measuring platelet count seems to be of no value. The possibility of screening for FAIT by typing pregnant women's platelet antigens is raised.

Original publication

DOI

10.1093/acprof:oso/9780192628268.003.0010

Type

Chapter

Book title

Antenatal and Neonatal Screening

Publication Date

01/09/2009